Invacare to Participate in the 6th Annual Needham Virtual Med Tech & Diagnostics 1×1 Conference

ELYRIA, Ohio–(BUSINESS WIRE)– Matt Monaghan, chairman, president and chief executive officer of Invacare (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations & corporate communications, will participate in 6th Annual Needham Virtual Med Tech & Diagnostics 1×1 Conference on Tuesday, August 17, 2021 .

The company’s management team will be available for 1×1 meetings with interested investors.

About Invacare

Invacare is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company’s products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific. For more information about the company and its products, visit Invacare’s website at www.invacare.com.

Source: Invacare

Previous Post
Invacare to Host Conference Call and Webcast to Discuss Second Quarter 2021 Financial Results
Next Post
Invacare Reports Strong Results for Second Quarter 2021